The Index › Metabolic medicine
Who carries the drugs to markets outside the United States?
The drugmakers and distributors outside the United States through which the drugs reach new markets.
The waterfall's proof point: Metabolic medicine: laboratory throughput is the productivity lift's nearest proof point, and it reports in pipeline data on a clock of quarters.
Businesses keep adopting AI, but the economy-wide productivity lift does not arrive before 2028.
What would prove us wrong
Productivity jumps much sooner than we expect, or adoption stops spreading.
Review 2027-12-31 · check: BLS Productivity and Costs (quarterly); Census Bureau Business Trends and Outlook Survey. · the claim's page
Reports next, in this group
Teva3 Nov · expected, per Nasdaq
| Company | What it sells | Reports next |
|---|---|---|
| Teva TEVA |
Teva sells generic, innovative and biosimilar medicines across many countries. | 3 Nov · expected, per Nasdaq |
Showing 1 of 1 · No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.
Next door
Whose science sits close to the new drugs? · Who works on longer, healthier lives? · Who makes the new weight-loss drugs?